Financhill
Sell
29

EVO Quote, Financials, Valuation and Earnings

Last price:
$3.2200
Seasonality move :
5031.82%
Day range:
$3.1800 - $3.2300
52-week range:
$2.8400 - $5.1000
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.38x
P/B ratio:
1.22x
Volume:
20.1K
Avg. volume:
82.4K
1-year change:
-29.48%
Market cap:
$1.1B
Revenue:
$862.1M
EPS (TTM):
-$0.50

Analysts' Opinion

  • Consensus Rating
    Evotec SE has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $5.4436, Evotec SE has an estimated upside of 69.18% from its current price of $3.2300.
  • Price Target Downside
    According to analysts, the lowest downside price target is $3.0051 representing 100% downside risk from its current price of $3.2300.

Fair Value

  • According to the consensus of 1 analyst, Evotec SE has 69.18% upside to fair value with a price target of $5.4436 per share.

EVO vs. S&P 500

  • Over the past 5 trading days, Evotec SE has underperformed the S&P 500 by -1.49% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Evotec SE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Evotec SE revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Evotec SE reported revenues of $191.5M.

Earnings Growth

  • Evotec SE earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Evotec SE reported earnings per share of -$0.14.
Enterprise value:
1.4B
EV / Invested capital:
0.95x
Price / LTM sales:
1.38x
EV / EBIT:
--
EV / Revenue:
1.73x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
-13.89x
Price / Operating cash flow:
100.09x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$87.5M
Return On Assets:
-8.33%
Net Income Margin (TTM):
-21.21%
Return On Equity:
-17.7%
Return On Invested Capital:
-11.62%
Operating Margin:
-31.17%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $819.4M $842.2M $832.2M $203.1M $191.5M
Gross Profit $204.3M $115.3M $87.5M $20.1M -$72.4K
Operating Income -$51M -$146.7M -$153.8M -$43.9M -$59.7M
EBITDA -$67.8M -$207.7M -- -- -$30.1M
Diluted EPS -$0.38 -$0.52 -$0.50 -$0.12 -$0.14
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $728.2M $1.1B $994.4M $779.1M $931.9M
Total Assets $2B $2.2B $2.4B $2.2B $2.1B
Current Liabilities $294.1M $333.9M $459.5M $372.3M $440M
Total Liabilities $898.4M $1B $1.2B $1.1B $1.1B
Total Equity $1.2B $1.2B $1.2B $1.1B $940.2M
Total Debt $580.2M $481.9M $470.6M $464.9M $455.6M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -- -$42.6M -$330.1K $45.2M -$75.3M
Cash From Investing -- -$138.5M -$46.7M -$28.8M -$12.1M
Cash From Financing -- -$105.3M -$16.4M -$7M -$11.6M
Free Cash Flow -- -$232M -$103.6M $14.2M -$101.3M
EVO
Sector
Market Cap
$1.1B
$28.4M
Price % of 52-Week High
63.33%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-0.98%
-1.32%
1-Year Price Total Return
-29.48%
-22.19%
Beta (5-Year)
1.821
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $3.2131
200-day SMA
Sell
Level $3.7841
Bollinger Bands (100)
Sell
Level 3.3028 - 4.0228
Chaikin Money Flow
Sell
Level -61.2M
20-day SMA
Buy
Level $3.1083
Relative Strength Index (RSI14)
Sell
Level 46.1698
ADX Line
Sell
Level 21.8791
Williams %R
Neutral
Level -26.087
50-day SMA
Sell
Level $3.5829
MACD (12, 26)
Sell
Level -0.1058
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Neutral
Level 16.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.6728)
Sell
CA Score (Annual)
Level (-0.7606)
Sell
Beneish M-Score (Annual)
Level (-1.8236)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (0.469)
Buy
Piotroski F Score (Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Stock Forecast FAQ

In the current month, EVO has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVO average analyst price target in the past 3 months is $5.4436.

  • Where Will Evotec SE Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Evotec SE share price will rise to $5.4436 per share over the next 12 months.

  • What Do Analysts Say About Evotec SE?

    Analysts are divided on their view about Evotec SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evotec SE is a Sell and believe this share price will drop from its current level to $3.0051.

  • What Is Evotec SE's Price Target?

    The price target for Evotec SE over the next 1-year time period is forecast to be $5.4436 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is EVO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Evotec SE is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of EVO?

    You can purchase shares of Evotec SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evotec SE shares.

  • What Is The Evotec SE Share Price Today?

    Evotec SE was last trading at $3.2200 per share. This represents the most recent stock quote for Evotec SE. Yesterday, Evotec SE closed at $3.2300 per share.

  • How To Buy Evotec SE Stock Online?

    In order to purchase Evotec SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
39
PSTG alert for Dec 5

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
38
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
69
ASTS alert for Dec 5

AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock